Mountain Diabetes and Endocrine Center
Quick facts
Marketed products
- Faster Insulin Aspart (Fiasp®) · Diabetes
Faster insulin aspart is a rapid-acting insulin analog that binds to insulin receptors to facilitate glucose uptake and utilization in peripheral tissues.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: